Trident Texofab Ltd — Updates, 12-05-2025: Company Update

Trident Texofab Limited has announced a board meeting outcome approving the conversion of 4,08,333 warrants into an equal number of equity shares at an issue price of Rs. 70 each (face value Rs. 10, premium Rs. 60). The company received Rs. 2.14 Cr as the balance payment for this conversion from non-promoter public investors, raising the paid-up capital to Rs. 13.97 Cr (1.39 crore shares). Additionally, the Board approved a postal ballot notice for appointing Mr. Katwala Sandip Fayeshkumar as a Non-Executive Independent Director, with e-voting to be scrutinized by M/s Amarceliya & Associates.